MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis
Aging · 2024
DOI: 10.18632/aging.205470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Jin Tao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Burning Rock Biotech, Guangzhou, Guangdong, China.
- Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
- Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.
Zitieren
APA
Tao, J., Cui, J., Xu, Y., Fan, Y., Hong, G., Zhou, Q., Wang, G., Li, L., Han, Y., Xu, C., Wang, W., Cai, S., & Zhang, X. (2024). MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis. Aging. https://doi.org/10.18632/aging.205470
Vancouver
Tao J, Cui J, Xu Y, Fan Y, Hong G, Zhou Q, et al. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis. Aging. 2024. doi:10.18632/aging.205470
BibTeX
@article{Tao2024,
author = {Tao, Jin and Cui, Jinshan and Xu, Yu and Fan, Yafeng and Hong, Guodong and Zhou, Qiaoxia and Wang, Guoqiang and Li, Leo and Han, Yusheng and Xu, Chunwei and Wang, Wenxian and Cai, Shangli and Zhang, Xuepei},
title = {MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205470}
}
EUVIMED